Open Access
Promoting music intervention training in oncology in China: Challenges, opportunities, and pathways forward
Vis Cancer Med, 5 (2024) 9
Published online: 06 December 2024
Visualized Cancer Medicine
Visualized Cancer Medicine is an interdisciplinary and peer-reviewed journal, which publishes the advances in basic, translational, and clinical studies on cancer biology, cancer prevention, cancer screening and diagnosis, cancer treatments, and cancer patient rehabilitation, with an emphasis on videos presenting the natural process, interventional procedure, and spatial alteration of the studied objects.
Visualized Cancer Medicine is the official journal of the Society of Tumor Microenvironment, China Anti-Cancer Association.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
-
-
Open Access
Artificial intelligence plus molecular profiling for personalized radiotherapy: Questions 105–107 in the 150 most important questions in cancer research and clinical oncology series
Vis Cancer Med, 5 (2024) 8Published online: 26 November 2024 -
Open AccessEditorial
Enhancing real-world studies with artificial intelligence: addressing ethical and quality challenges
Vis Cancer Med, 5 (2024) E3Published online: 31 October 2024 -
Open AccessReview
Comparison of cyclotron and synchrotron in particle therapy
Vis Cancer Med, 5 (2024) 7Published online: 31 July 2024 -
Open AccessReview
Updates on altered signaling pathways in tumor drug resistance
Vis Cancer Med, 5 (2024) 6Published online: 22 July 2024 -
Open Access
Quasi-experimental design for external control arm studies alongside single arm trials for regulatory purposes
Vis Cancer Med, 5 (2024) 5Published online: 10 June 2024 -
Open AccessReview
Beam range uncertainty and its clinical management in particle therapy
Vis Cancer Med, 5 (2024) 4Published online: 22 May 2024 -
Open Access
The 150 most important questions in cancer research and clinical oncology series: questions 102–104
Vis Cancer Med, 5 (2024) E2Published online: 06 May 2024
| 166 |
Open Access
Review
Metastasis of nasopharyngeal carcinoma: What we know and do not knowVis Cancer Med, 2 (2021) 4
Published online: 11 August 2021
|
| 145 |
Open Access
Review
Comparison of cyclotron and synchrotron in particle therapyVis Cancer Med, 5 (2024) 7
Published online: 31 July 2024
|
| 79 |
Open Access
Challenges and benefits of implementing DIBH for breast cancer radiotherapy: Experiences from Guangzhou Concord Cancer CenterVis Cancer Med, 4 (2023) 8
Published online: 20 December 2023
|
| 66 |
Open Access
Review
Functions of glutaminyl cyclase and its isoform in diseasesVis Cancer Med, 4 (2023) 1
Published online: 06 January 2023
|
| 56 |
Open Access
Review
Updates on altered signaling pathways in tumor drug resistanceVis Cancer Med, 5 (2024) 6
Published online: 22 July 2024
|
| 9 |
Open Access
An increase in early cancer detection rates at a single cancer center: Experiences from Sun Yat-sen University Cancer CenterVis Cancer Med, 3 (2022) 1
Published online: 01 March 2022
|
| 9 |
Open Access
Review
Metastasis of nasopharyngeal carcinoma: What we know and do not knowVis Cancer Med, 2 (2021) 4
Published online: 11 August 2021
|
| 9 |
Open Access
Spatially-resolved proteomics and transcriptomics: An emerging digital spatial profiling approach for tumor microenvironmentVis Cancer Med, 2 (2021) 1
Published online: 03 March 2021
|
| 8 |
Open Access
Review
Functions of glutaminyl cyclase and its isoform in diseasesVis Cancer Med, 4 (2023) 1
Published online: 06 January 2023
|
| 4 |
Open Access
Review
MxA: a broadly acting effector of interferon-induced human innate immunityVis Cancer Med, 3 (2022) 2
Published online: 06 April 2022
|
